Navigation Links
Migraine in Medical Technology
... development plans for AZ-104 for the
treatment of migraine headaches."
About Acute migraine Headaches
According to the National ... in the United States have been diagnosed with migraine ...
... that COL-144 was safe and effective in relieving migraine headaches. COL-144 is a first-in-class Neurally ... The randomized, double-blind study evaluated 130 migraine patients. Patients were not on prophylaxis and ... 20 minutes as first-line treatment of an acute migraine attack. The primary end-point parameter was ...
... a 306-patient Phase IIb clinical trial in acute migraine headache. Specifically, tezampanel demonstrated ... "This is our second positive study in acute migraine with tezampanel," said Neil Kurtz, M.D., ... a number of diseases and disorders. These include migraine and other forms of chronic pain such as ...
... study, MAP0004 stimulated receptors that relieve migraine at levels comparable to IV DHE, but did not ... in a Phase 2 study is also important because migraine and asthma are frequently co-morbid conditions." ... the MAP0004 program, including: -- Newer Acute migraine Specific Drugs May Provide Improved ...
... discuss the opportunity of treating chronic pain, migraine and muscle spasticity through the inhibition of ... the brain as a target for acute and prophylactic migraine therapy. He is a member of the American ... clearly a promising approach for the treatment of migraine and other conditions." TorreyPines ...
... loxapine (AZ-104) for the treatment of migraine headache at the 50th Annual Scientific Meeting ... Reduces Headache Pain in Patients Having an Acute migraine Attack", is scheduled for Friday, June 27, 2008 ... (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for ...
... Show Significant Improvements With ROX-828 In migraine Pain And Related Symptoms For Up to 48 ... one dose of study drug when they experienced a migraine attack. "While in-depth analysis of the data is ... may offer a meaningful advantage for patients." migraine is a common recurring condition marked by severe, ...
... provided significantly more patients migraine pain relief compared to sumatriptan 85 mg ... has approved Treximet for the acute treatment of migraine attacks with or without aura in adults. Treximet is the first and only migraine product designed to target multiple mechanisms ...
... of AZ-104 (Staccato(R) loxapine) in patients with migraine headache. migraine is a debilitating, yet common neurological ... designed to evaluate the treatment of a single migraine attack in each of ...
... II clinical trial of tezampanel in acute migraine headache. As reported last October, ... utility of tezampanel for indications beyond migraine and chronic pain. -- Complete the ... for tezampanel and NGX426 as treatments for migraine headache and other chronic pain and non-pain ...
... clinical trial of tezampanel in 306 patients with migraine met its primary endpoint for pain relief at two ... the transmission of pain signals that lead to migraine headaches. The blockade of similar receptors in ... prove to be safe and effective treatments for migraine and other pain conditions as well as non-pain ...
... is being developed for the acute treatment of migraine headaches. Alexza reported positive results from ... is being developed for the acute treatment of migraine headaches. In December 2007, Alexza ... clinical trial with AZ-104 in patients with migraine headache. The Phase 2a clinical trial was an ...
... to Initiate Phase IIa Study of NGX426 in Acute migraine in First Half of 2008 - ... NGX426 also may be effective in treating acute migraine headache. TorreyPines Therapeutics plans to initiate a Phase IIa study of NGX426 in acute migraine in the first half of 2008. "These findings with ...
... Placebo-Controlled Dose-Escalating Study in migraine patients was successfully completed. This event ... of MTR106 in female patients suffering from migraine without aura. The study population consisted of ... 22-57 years of age. The average duration of migraine attacks was 16.6 +/- 10 hours with a frequency of ...
... (Nasdaq: TPTX ) for the treatment of acute migraine headache, was shown in an independent study to be ... CNS therapies for chronic pain, including migraine and neuropathic pain; and cognitive disorders, ... the potential for tezampanel as a treatment for migraine and other pain indications, the potential for ...
... trial of tezampanel for the treatment of acute migraine headache. Tezampanel is an AMPA/kainate (AK) ... new and promising alternative to current migraine treatments. The clinical trial is a ... enrollment of 300 patients suffering a single migraine attack, with or without aura. Patients are ...
... the potential to treat a number of diseases and disorders. These include migraine and other forms of chronic pain such as neuropathic pain, muscle ... analgesic and the potential for tezampanel and NGX426 as treatments for migraine and other forms of chronic pain such as neuropathic pain, muscle ...
... neuralgia; PERCOCET(R) and PERCODAN(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; ...
... Company has completed its end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine), which is intended for the acute treatment of migraine headache, and it has advanced AZ-104 (Staccato loxapine) to Phase 2 testing. Product candidates that have completed Phase 1 testing are AZ-003 ...
... solutions that improve neurological health. The company currently markets products for Alzheimer's disease, epilepsy and acute and preventive migraine treatment. In conjunction with internal and external research partners, Ortho-McNeil Neurologics continues to explore new opportunities to develop ...
... or bipolar disorder patients, has completed one Phase 3 clinical trial and the second Phase 3 clinical trial ongoing. For the acute treatment of migraine headaches, AZ-001 (Staccato prochlorperazine) has completed Phase 2 testing and AZ-104 (Staccato loxapine) is in Phase 2 testing. Product candidates ...
... prochlorperazine) for the acute treatment of migraine headaches has completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. Product ...
Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
... in Denmark of tonabersat in the prevention of migraine with aura. The median number of aura attacks was ... in favor of tonabersat compared with placebo. migraine with aura affects around 30 percent of migraine sufferers and is a type ...Swedish in Seattle to Study Connections Between Preeclampsia and Migraine
... her co-investigator Sheena Aurora, M.D., a migraine specialist with the Swedish Pain and Headache ... pre-gestational history of migraines and migraine symptoms during early pregnancy are associated ... cause of maternal and infant illness and death. migraine is a common chronic-episodic disorder ...... that COL-144 was safe and effective in relieving migraine headaches. COL-144 is a first-in-class Neurally ... The randomized, double-blind study evaluated 130 migraine patients. Patients were not on prophylaxis and ... 20 minutes as first-line treatment of an acute migraine attack. The primary end-point parameter was ...
Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
... AZ-001 to treat patients suffering from acute migraine headaches. Alexza requested an end of Phase 2 ... AZ-104 to treat patients suffering from acute migraine headaches. AZ-104 is a lower dose version of ... allowed to conduct the first patient study in migraine patients, the Phase 2a proof-of-concept trial ...MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
... study of healthy volunteers. "Asthma and migraine have a high incidence of co-morbidity, so it ... has a long history of use as a safe and effective migraine treatment. Many headache specialists consider DHE ... to be the standard of care in treating chronic migraine and debilitating migraines that last more than 72 ...MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
... has the potential to be a first-line therapy for migraine patients," said Timothy S. Nelson, president and ... has a long history of use as a safe and effective migraine treatment. Many headache specialists consider DHE ... to be the standard of care in treating chronic migraine and debilitating migraines that last more than 72 ...... a 306-patient Phase IIb clinical trial in acute migraine headache. Specifically, tezampanel demonstrated ... "This is our second positive study in acute migraine with tezampanel," said Neil Kurtz, M.D., ... a number of diseases and disorders. These include migraine and other forms of chronic pain such as ...
... study, MAP0004 stimulated receptors that relieve migraine at levels comparable to IV DHE, but did not ... in a Phase 2 study is also important because migraine and asthma are frequently co-morbid conditions." ... the MAP0004 program, including: -- Newer Acute migraine Specific Drugs May Provide Improved ...
Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
... device would help an estimated 39 percent of migraine sufferers. The device, about the size and ... ticket to help relieve the pain of chronic migraine sufferers. Occipital nerve stimulation, in which ... has been shown to help 40 percent of near-daily migraine sufferers who don't have success with ...... discuss the opportunity of treating chronic pain, migraine and muscle spasticity through the inhibition of ... the brain as a target for acute and prophylactic migraine therapy. He is a member of the American ... clearly a promising approach for the treatment of migraine and other conditions." TorreyPines ...
... loxapine (AZ-104) for the treatment of migraine headache at the 50th Annual Scientific Meeting ... Reduces Headache Pain in Patients Having an Acute migraine Attack", is scheduled for Friday, June 27, 2008 ... (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for ...
... Show Significant Improvements With ROX-828 In migraine Pain And Related Symptoms For Up to 48 ... one dose of study drug when they experienced a migraine attack. "While in-depth analysis of the data is ... may offer a meaningful advantage for patients." migraine is a common recurring condition marked by severe, ...
... provided significantly more patients migraine pain relief compared to sumatriptan 85 mg ... has approved Treximet for the acute treatment of migraine attacks with or without aura in adults. Treximet is the first and only migraine product designed to target multiple mechanisms ...
Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
... is being developed for the acute treatment of migraine headaches. Alexza reported positive results from ... is being developed for the acute treatment of migraine headaches. AZ-104 is a lower dose version of ... (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for ...... of AZ-104 (Staccato(R) loxapine) in patients with migraine headache. migraine is a debilitating, yet common neurological ... designed to evaluate the treatment of a single migraine attack in each of ...
... II clinical trial of tezampanel in acute migraine headache. As reported last October, ... utility of tezampanel for indications beyond migraine and chronic pain. -- Complete the ... for tezampanel and NGX426 as treatments for migraine headache and other chronic pain and non-pain ...
... clinical trial of tezampanel in 306 patients with migraine met its primary endpoint for pain relief at two ... the transmission of pain signals that lead to migraine headaches. The blockade of similar receptors in ... prove to be safe and effective treatments for migraine and other pain conditions as well as non-pain ...
... is being developed for the acute treatment of migraine headaches. Alexza reported positive results from ... is being developed for the acute treatment of migraine headaches. In December 2007, Alexza ... clinical trial with AZ-104 in patients with migraine headache. The Phase 2a clinical trial was an ...
Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
... placebo-controlled study in approximately 160 migraine patients with or without aura. Three doses ... during the first quarter of 2008." About Acute migraine Headaches According to the National Headache ... in the United States have been diagnosed with migraine ...... to Initiate Phase IIa Study of NGX426 in Acute migraine in First Half of 2008 - ... NGX426 also may be effective in treating acute migraine headache. TorreyPines Therapeutics plans to initiate a Phase IIa study of NGX426 in acute migraine in the first half of 2008. "These findings with ...
... Placebo-Controlled Dose-Escalating Study in migraine patients was successfully completed. This event ... of MTR106 in female patients suffering from migraine without aura. The study population consisted of ... 22-57 years of age. The average duration of migraine attacks was 16.6 +/- 10 hours with a frequency of ...
Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
... trial for the treatment of a single, acute migraine attack. In the study, which evaluated tezampanel ... disability and a composite score of core migraine symptoms at two and four hours post-dose that ... in order to initiate a Phase III program in acute migraine in the second half of 2008. In this trial, all ...... (Nasdaq: TPTX ) for the treatment of acute migraine headache, was shown in an independent study to be ... CNS therapies for chronic pain, including migraine and neuropathic pain; and cognitive disorders, ... the potential for tezampanel as a treatment for migraine and other pain indications, the potential for ...
TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
... Currently in Phase IIb Clinical Trial for Acute migraine - LA JOLLA, Calif., Aug. 27 ... development of tezampanel for the treatment of migraine as well as allow TorreyPines to consider ... Officer of TorreyPines. "Our Phase IIb trial in migraine has completed enrollment and we are on track to ...... trial of tezampanel for the treatment of acute migraine headache. Tezampanel is an AMPA/kainate (AK) ... new and promising alternative to current migraine treatments. The clinical trial is a ... enrollment of 300 patients suffering a single migraine attack, with or without aura. Patients are ...
Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
... Alexza is developing AZ-104 to treat patients suffering from acute migraine headaches. AZ-104 is a lower dose version of AZ-004. In January 2009, ... Both product candidates are being developed for the acute treatment of migraine headache. AZ-002 ( Staccato alprazolam) has completed Phase 1 testing ...Study Confirms: Your Hidden Food Allergies Are Making You Fat
... benefit of The ALCAT Test to help chronic symptoms such as obesity, IBS, migraine and arthritis. DEERFIELD BEACH, Fla., April 6 /PRNewswire/ -- Medical ... Food sensitivities often provoke delayed and chronic symptoms, like IBS, migraine and arthritis, that are not as obvious as the dramatic and immediate onset ...... the potential to treat a number of diseases and disorders. These include migraine and other forms of chronic pain such as neuropathic pain, muscle ... analgesic and the potential for tezampanel and NGX426 as treatments for migraine and other forms of chronic pain such as neuropathic pain, muscle ...
deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
... and U01 HL65962 and American Heart Association grant 0940116N; by the German Federal Ministry of Education and Research (01GI9909/3), by the German migraine & Headache Society (DMKG), and by unrestricted grants of equal share from Astra Zeneca, Berlin Chemie, Boots Healthcare, Glaxo-Smith-Kline, ...Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
... neuralgia; PERCOCET(R) and PERCODAN(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; ...FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
... neuralgia; PERCOCET(R) and PERCODAN(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; ...... neuralgia; PERCOCET(R) and PERCODAN(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; ...
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
... neuralgia; PERCOCET(R) and PERCODAN(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; ...... Company has completed its end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine), which is intended for the acute treatment of migraine headache, and it has advanced AZ-104 (Staccato loxapine) to Phase 2 testing. Product candidates that have completed Phase 1 testing are AZ-003 ...
... solutions that improve neurological health. The company currently markets products for Alzheimer's disease, epilepsy and acute and preventive migraine treatment. In conjunction with internal and external research partners, Ortho-McNeil Neurologics continues to explore new opportunities to develop ...
... or bipolar disorder patients, has completed one Phase 3 clinical trial and the second Phase 3 clinical trial ongoing. For the acute treatment of migraine headaches, AZ-001 (Staccato prochlorperazine) has completed Phase 2 testing and AZ-104 (Staccato loxapine) is in Phase 2 testing. Product candidates ...
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
... as adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome. TOPAMAX(R) is indicated in adults for the prophylaxis of migraine headache. Important Safety Information: Serious risks associated with TOPAMAX include lowered bicarbonate levels in the blood resulting in an ...Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
... prochlorperazine) for the acute treatment of migraine headaches has completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. Product ...... prochlorperazine) for the acute treatment of migraine headaches has completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. Product ...
Other ContentsOther TagsOther Tags
(Date:5/16/2013)... Injectable nanoparticles developed at MIT may someday eliminate ... to constantly monitor their blood-sugar levels and inject ... to sense glucose levels in the body and ... thereby replacing the function of pancreatic islet cells, ... diabetes. Ultimately, this type of system could ensure ...
(Date:5/16/2013)... May 16, 2013 Integrated Biometrics patented ... a custom thin film transistor camera introduces Sherlock, ... roll image in the smallest and lightest form ... Appendix F Mobile ID FAP 45, Certified scanner ... in size and weight when compared to optical ...
(Date:5/16/2013)... The use of genome-wide analysis (GWA), where the entirety ... the genomic mutations or variants which can cause health ... However, it can also pose major ethical problems ... Society of Human Genetics (ESHG) published on line today ... Human Genetics ., Many services based on whole genome ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2(Date:5/18/2013)... York, NY (PRWEB) May 18, 2013 After ... consistent efforts, SizeItUp formally announced the integration of ... redesigned 2012 Hyundai Genesis is set to stun the automobile ... and style. 2012 Hyundai Genesis is marked as the latest ... and heads the vehicles lined up for the year 2013. ...
(Date:5/18/2013)... As metal-on-metal hip implant ... Bernstein Liebhard LLP notes that a new study has ... damage before they experience any pain from a hip. ... will appear in the Journal of Bone & Joint ... of their hips. The researchers found tissue damage ...
(Date:5/18/2013)... Simple changes in a person’s every day routine, ... water can lead to substantial health benefits, the proven ... Diet Doc understands that overcoming significant weight ... difficult and often requires the use of prescription strength ... get over initial weight loss hurdles. In addition to ...
(Date:5/18/2013)... May 18, 2013 Adolescents, especially young ... as “Spice” or “K2” are landing in emergency rooms ... curb this drug epidemic with a new treatment ... , According to research from the National Institute on ... illegal drug among American teenagers. In 2012, 11 percent ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The California ... 2013 therapies. At the Ayurvedic Spa , the ... panchakarma practitioner and lifestyle recommendations and stress ... “knowledge of life", is the traditional healthcare system of ... life of harmony is the basis for all optimum ...
Breaking Medicine News(10 mins):Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center 2[0] Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis[0] Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients[0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments[0] Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates[0] Ayurveda Spa Treatments Now Offered at the California College of Ayurveda Panchakarma Center
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |